Patents by Inventor Paul Warrener

Paul Warrener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100081178
    Abstract: This disclosure describes genetically modified photosynthetic microorganisms, including Cyanobacteria, that contain one or more exogenous genes encoding a diacylglycerol acyltransferase, a phosphatidate phosphatase, and/or an acetyl-CoA carboxylase, and which are capable of producing increased amounts of fatty acids and/or synthesizing triglycerides.
    Type: Application
    Filed: October 23, 2009
    Publication date: April 1, 2010
    Applicant: TARGETED GROWTH, INC.
    Inventors: James Roberts, Fred Cross, Paul Warrener, Ernesto Javier Munoz, Martin Henry Lee, Khadidja Romari
  • Patent number: 7629141
    Abstract: The invention includes a database of candidate essential genes in Pseudomonas aeruginosa, as well as other important genes that, when mutated, lead to a growth attenuated phenotype. Such genes and mutants of such genes are important for identifying antibacterial agents suitable for treating and preventing Pseudomonas aeruginosa infections. The invention includes methods for confirming the essentiality or importance of candidate genes, as well as methods for utilizing those genes to screen for new antibacterial drugs. The invention also includes the antibacterial agents identified using the disclosed methods, as well as methods of using the same for treating and preventing Pseudomonas infection.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: December 8, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Kim Folger Bruce, Paul Warrener, Kevin Hou
  • Publication number: 20070196829
    Abstract: The invention includes a database of candidate essential genes in Pseudomonas aeruginosa, as well as other important genes that, when mutated, lead to a growth attenuated phenotype. Such genes and mutants of such genes are important for identifying antibacterial agents suitable for treating and preventing Pseudomonas aeruginosa infections. The invention includes methods for confirming the essentiality or importance of candidate genes, as well as methods for utilizing those genes to screen for new antibacterial drugs. The invention also includes the antibacterial agents identified using the disclosed methods, as well as methods of using the same for treating and preventing Pseudomonas infection.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 23, 2007
    Applicant: CHIRON CORPORATION
    Inventors: Kim Bruce, Paul Warrener, Kevin Hou
  • Publication number: 20060234233
    Abstract: The invention provides a method for generating a database of candidate essential genes in Staphylococcus aureus, as well as otherwise important genes that, when mutated, lead to a growth attenuated phenotype. Such genes and mutants of such genes are important for identifying antibacterial agents suitable for treating and preventing S. aureus infections. The invention includes methods for confirming the essentiality or importance of candidate genes, as well as methods for utilizing those genes to screen for new antibacterial drugs. The invention also includes the antibacterial agents identified using the disclosed methods, as well as methods of using the same for treating and preventing Staphylococcus infection.
    Type: Application
    Filed: August 20, 2003
    Publication date: October 19, 2006
    Applicant: CHIRON CORPORATION
    Inventors: Kim Bruce, Paul Warrener, Jennifer McLarnan, Kevin Hou